^
Association details:
Biomarker:ALK positive
Cancer:Neuroblastoma
Drug Class:CAR-T immunotherapy
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Title:

Generation of ALK CAR-T Cells for Neuroblastoma Therapy

Published date:
05/28/2021
Excerpt:
To specifically target NB cells, we developed a series of ALK chimeric antigen receptor (CAR) T constructs from antibodies that recognize both human and mouse ALK....Murine ALK CAR-T cells are able to control the growth of ALK+...NB in syngeneic tumor models without detectable toxicity.